OSTO:GETI B (Sweden)
Business Description
Getinge AB
NAICS : 339112
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Compare
Compare
Traded in other countries / regions
GTN.Germany
•
GETIB.Mexico
•
GETI B.Sweden
•
0GZV.UK
•
GNGBF.USA
Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (57% of revenue), surgical workflows (30%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 0.97 | |||||
Interest Coverage | 23.94 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.57 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | 56.6 | |||||
3-Year FCF Growth Rate | 71.1 | |||||
3-Year Book Growth Rate | 8.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Industry Rank | 3.24 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 3.76 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.13 | |||||
9-Day RSI | 39.66 | |||||
14-Day RSI | 39.49 | |||||
6-1 Month Momentum % | -31.87 | |||||
12-1 Month Momentum % | -34.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.96 | |||||
Quick Ratio | 4.44 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 136.04 | |||||
Days Sales Outstanding | 56.2 | |||||
Days Payable | 47.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.81 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 26 | |||||
Forward Dividend Yield % | 1.81 | |||||
5-Year Yield-on-Cost % | 1.7 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.91 | |||||
Operating Margin % | 13.67 | |||||
Net Margin % | 9.82 | |||||
ROE % | 10.7 | |||||
ROA % | 5.96 | |||||
ROIC % | 6.9 | |||||
ROC (Joel Greenblatt) % | 31.83 | |||||
ROCE % | 9.31 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.73 | |||||
Forward PE Ratio | 18.98 | |||||
PE Ratio without NRI | 22.55 | |||||
Shiller PE Ratio | 30.6 | |||||
Price-to-Owner-Earnings | 20.88 | |||||
PEG Ratio | 1.94 | |||||
PS Ratio | 2.23 | |||||
PB Ratio | 2.18 | |||||
Price-to-Tangible-Book | 42.34 | |||||
Price-to-Free-Cash-Flow | 19.62 | |||||
Price-to-Operating-Cash-Flow | 14.64 | |||||
EV-to-EBIT | 17.4 | |||||
EV-to-Forward-EBIT | 14.96 | |||||
EV-to-EBITDA | 11.8 | |||||
EV-to-Forward-EBITDA | 10.58 | |||||
EV-to-Revenue | 2.43 | |||||
EV-to-Forward-Revenue | 2.32 | |||||
EV-to-FCF | 21.17 | |||||
Price-to-Projected-FCF | 1.14 | |||||
Price-to-Median-PS-Value | 1.36 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.97 | |||||
Price-to-Graham-Number | 6.54 | |||||
Earnings Yield (Greenblatt) % | 5.74 | |||||
Forward Rate of Return (Yacktman) % | 25.28 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 27,146 | ||
EPS (TTM) (kr) | 9.78 | ||
Beta | 1.34 | ||
Volatility % | 31.17 | ||
14-Day RSI | 39.49 | ||
14-Day ATR (kr) | 7.365107 | ||
20-Day SMA (kr) | 228.805 | ||
12-1 Month Momentum % | -34.65 | ||
52-Week Range (kr) | 203.7 - 431.6 | ||
Shares Outstanding (Mil) | 272.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Getinge AB Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |